95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Maria Fiorella Contarino1,2
Marenka Smit3
Joost van den Dool3,4,5
Jens Volkmann6†
Marina A. J. Tijssen3*†
- 1Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands
- 2Department of Neurology, Haga Teaching Hospital, Den Haag, Netherlands
- 3Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
- 4Faculty of Health, ACHIEVE Centre of Applied Research, Amsterdam University of Applied Sciences, Amsterdam, Netherlands
- 5Department of Neurology, Academic Medical Center, Amsterdam, Netherlands
- 6Department of Neurology, University Clinic of Würzburg, Würzburg, Germany
A Corrigendum on
Description of the Mistake Being Fixed
In the original article, we neglected to thank our sponsor, European Cooperation in Science and Technology (COST), Action BM1101 “European network for the study of dystonia syndromes.” The authors apologize for this oversight.
This error does not change the scientific conclusions of the article in any way.
The correct text of the acknowledgments should read as below.
Acknowledgments and Funding
This work was supported by European Cooperation in Science and Technology (COST) Action BM1101 “European network for the study of dystonia syndromes”.
Conflict of Interest Statement
MC, Advisory board: Medtronic, Boston Scientific, is co-inventor on a patent application relevant to Deep Brain Stimulation (2014). Speaking fees: Abbvie, Medtronic, Boston Scientific, ECMT. Grant: Stichting Parkinson Fonds. MS: Grants: University Medical Centre Groningen, Stichting Wetenschapsfonds Dystonie Vereniging. JD: Grants: Dutch organizations in scientific research, the Fonds Nutsohra, Jacques and Gloria Gossweiler foundation and Stichting Wetenschapsfonds Dystonie Vereniging. JV: advisory boards: Boston Scientific, Medtronic; grant support: Boston Scientific, Medtronic; Speaking fees: Boston Scientific, Medtronic, St. Jude, UCB, TEVA, and Allergan. MT: Grants: Netherlands organization for scientific research-NWO, Medium, Fonds NutsOhra, Prinses Beatrix Fonds, Gossweiler foundation, Stichting wetenschapsfonds dystonie vereniging, Phelps Stichting, educational grants and national DystonieNet grants from Ipsen and Allergan Famaceutics, Merz, Medtronic and Actelion.
Keywords: cervical dystonia, botulinum toxin, deep brain stimulation, physical therapy modalities, non-motor features
Citation: Contarino MF, Smit M, van den Dool J, Volkmann J and Tijssen MAJ (2016) Corrigendum: Unmet Needs in the Management of Cervical Dystonia. Front. Neurol. 7:232. doi: 10.3389/fneur.2016.00232
Received: 15 November 2016; Accepted: 02 December 2016;
Published: 19 December 2016
Edited and Reviewed by: Alberto Albanese, Catholic University of the Sacred Heart, Italy
Copyright: © 2016 Contarino, Smit, van den Dool, Volkmann and Tijssen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Marina A. J. Tijssen, bS5hLmouZGUua29uaW5nLXRpanNzZW5AdW1jZy5ubA==
†Jens Volkmann and Marina A. J. Tijssen contributed equally to the manuscript.